Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,269 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Supreme Court Dismisses Appeal From The Bench In Sanofi-Aventis v. Apotex, Inc.

    On April 21st, 2015, the Supreme Court of Canada dismissed from the bench an appeal from the Federal Court of Appeal decision in Apotex Inc. v. Sanofi-Aventis, 2014 FCA 68.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Declines To Overturn Prohibition On Patenting Methods Of Medical Treatment

    The Supreme Court of Canada has issued a landmark ruling on whether methods of medical treatment can be patented in Canada, addressing a long-standing prohibition that has shaped the country's intellectual property landscape. The decision examines the boundaries between patentable medical innovations and unpatentable professional medical judgment, with particular focus on dosing regimens and treatment protocols. This ruling provides critical guidance for pharmaceutical companies, patent practitioners, and h
    Canada
Intellectual Property
Oyen Wiggs Green & Mutala
Oyen Wiggs Green & Mutala
  • Article

    Supreme Court Of Canada Denies Amgen Leave To Appeal Decision Invalidating Its Filgrastim Patent

    As previously reported, Amgen sought leave to appeal a decision of the Federal Court of Appeal (2020 FCA 188) affirming Justice Southcott's decision that the relevant claims of its filgrastim (NEUPOGEN)
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Denies Leave To Appeal In "PM(NOC)" Judicial Comity Case

    The Supreme Court of Canada has recently denied leave to appeal from the Federal Court of Appeal decision in "Allergan Inc. et al ats. Apotex Inc.".
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Dismisses Apotex's Application For Leave To Appeal Macitentan Inducing Infringement Decision

    As previously reported, the Federal Court of Appeal dismissed Apotex's appeal of a decision relating to macitentan (Janssen's OPSUMIT), which found that Apotex would induce infringement of Janssen's patent.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Leave Applications

    Eli Lilly seeks leave in olanzapine section 8 damages action.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Leave Applications

    As previously reported, the Federal Court of Appeal (FCA) dismissed Teva's appeal on the quantification of damages from infringement of Janssen's patent for levofloxacin (LEVAQUIN).
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Supreme Court Of Canada Strikes Down "Promise Doctrine", Upholds AstraZeneca's NEXIUM Patent As Useful

    On June 30, the Supreme Court of Canada (SCC) delivered its highly anticipated decision, AstraZeneca v Apotex, 2017 SCC 36 relating to esomeprazole (NEXIUM).
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    The Latest Developments In Life Sciences IP Litigation (Video)

    Amid this year's disruptions to IP litigation, we have seen high-impact developments affecting life sciences companies.
    CanadaIntellectual Property
    Torys
    Torys
  • Video

    The Legal Steps To Startups: What You Need To Know About Patents (Video)

    Welcome to the next video in our Legal Steps to Startups Video Series – What You Need to Know About Patents. What is a patent? Why should you think about hiring a patent agent...
    CanadaIntellectual Property
    Parlee McLaws LLP
    Parlee McLaws LLP
  • Article

    Update On CIPO Operations And Services

    In light of the disruption caused by COVID-19, the Canadian Intellectual Property Office ("CIPO") announced that any deadlines imposed by the Patent Act
    CanadaIntellectual Property
    Goodmans LLP
    Goodmans LLP
  • Article

    US Patent Term Adjustment Final Rules

    On January 9, 2015, the USPTO published its final rules implementing changes to patent term adjustment (PTA), in view of the US Federal Circuit decision in Novartis v Lee.
    CanadaIntellectual Property
    Bennett Jones LLP
    Bennett Jones LLP
  • Article

    USPTO Patent Eligibility Guidelines

    What is eligible to be patented in the US? This week the U.S. Patent and Trademark Office (USPTO) released Interim Eligibility Guidance on patent subject matter eligibility.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Video: IP Divisional Patent Application

    What is a divisional patent application? Should inventors be engaged in the patent application process?
    CanadaIntellectual Property
    Torys
    Torys
  • Article

    Video: What Does A New Ruling On Canada's Equivalent To Patent Term Extension Mean For The Pharmaceutical Industry?

    Last week, we wrote about the Federal Court's latest judicial review which sheds light on how courts may view eligibility of patents for Canada's recently introduced Certificates of Supplementary Protection (CSPs).
    CanadaIntellectual Property
    Torys
    Torys
  • Video

    What Does A New Ruling On Canada's Equivalent To Patent Term Extension Mean For The Pharmaceutical Industry? (Video)

    What does a new ruling on Canada's equivalent to patent term extension mean for the pharmaceutical industry?
    CanadaIntellectual Property
    Torys
    Torys
  • Article

    Lifecycle Of A Smart Idea: Patent And Trade Secret Stream

    As 2020 quickly draws to a close, time is running out to fulfill your Continuing Professional Development (CPD) credits for the year.
    GlobalIntellectual Property
    Gowling WLG
    Gowling WLG
  • Article

    Patent Disclosure Requirements For Therapeutic Antibody Patents

    Therapeutic antibodies have grown to become an important product class within the biopharmaceutical market.
    GlobalIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    2017-2018 Statistical Report For PMNOC Regulations And Data Protection

    The Report includes information regarding trends in listing on the Patent Register and the Register of Innovative Drugs, as well as related court activity.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Cannabis Litigation Update: United Cannabis Corp v Pure Hemp Collective Inc.

    Last September, before the new world of legalized recreational cannabis had opened-up in Canada, we reported on the state of IP litigation in the cannabis industry.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Showing 241–260 of 4269 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics